Loading
Latest filing published 13 Feb 2023 for Axcella Health Inc., €3,209.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Paul Fehlner (senior executive) discloses dealings in Axcella Health Inc. to SEC (Form 4). Over a trading history stretching from 16 March 2022 to 10 February 2023, the count stands at 2 filings.
The open-market side counts 1 purchase for €18k alongside 1 sale for €3,209. Netting one side against the other leaves €15k of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2023 alone, the filings show no purchases and 1 sale.
Most recently, on 13 February 2023, the filings show an open-market sale worth €3,209 in Axcella Health Inc. The clock since the last published purchase (18 March 2022) now reads 1,681 days. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations